A new study suggests that an older GLP-1 drug may help protect the brains of people with early Alzheimers disease, supporting the case for further research on the class of medications originally developed for obesity and diabetes in neurological diseases
Fat dissolving injections can help reduce the fat that contributes to cellulite, improving the skins texture and appearance
Fan H, Gong N, Li TF, Ma AN, Wu XY, Wang MW, Wang YX (2015) The non-peptide GLP-1 receptor agonist WB4-24 blocks inflammatory nociception by stimulating beta-endorphin release from spinal microglia
Description KLOW 80mg KLOW 80mg is offered as a lyophilized research compound intended for laboratory and analytical research applications
Genetic predisposition, environmental factors, gut microbiota dysbiosis and defective bidirectional gutbrain communication have been identified as possible contributors to autoimmune diseases